Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
HPV screening: Primary human papilloma virus DNA screening with Qiagen/Digene's Hybrid Capture 2 followed by cytology triage is more sensitive in detecting cervical lesions than conventional cytology screening, according to a large-scale Finnish study published in the Dec. 2 issue of the Journal of the National Cancer Institute. In women 35 or older, the method also showed greater specificity and decreased colposcopy referrals and follow-up tests. An accompanying editorial by Eduardo L. Franco, McGill University, notes that as more young women who have received the HPV vaccine reach screening age, "the reduced prevalence of abnormalities may adversely affect the performance of cytology if it is left as the sole screening test.
You may also be interested in...
Qiagen's HC2 More Effective Than Pap Test In Preventing Cancer - Study
Qiagen/Digene's Hybrid Capture 2 human papillomavirus (HPV) DNA test is more effective than Pap testing alone in preventing cervical cancer, according to the results of a large-scale study published online Jan. 19 in The Lancet Oncology
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.